AbbVie, Inc. (ABBV)

210.26 +3.79 (+1.84%) USD  |  NYSE  |  Apr 14, 16:00
208.55 -1.71 (-0.81%) Pre-Market: 07:48
More

AbbVie Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade